Q3 2020 Holdings
Filed 2020-11-16 | 22 holdings | $232.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc.(ARQT) | COM | 03969K108 | $116.6M | 3,979,292 | 50.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $98.0M | 3,241,628 | 42.2% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $16.8M | 1,071,428 | 7.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $347.1K | 7,281,307 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $73.4K | 4,080,237 | 0.0% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $64.2K | 3,445,667 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $48.9K | 2,122,415 | 0.0% |
| Dynavax Technologies Corp.(DVAX) | COM | 268158201 | $47.1K | 10,895,773 | 0.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $44.8K | 1,284,314 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $30.5K | 499,100 | 0.0% |
| Constellation Pharmaceuticals Inc.(CNST) | COM | 210373106 | $28.4K | 1,400,000 | 0.0% |
| Kymera Therapeutics Inc.(KYMR) | COM | 501575104 | $23.6K | 729,606 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $23.0K | 5,128,593 | 0.0% |
| Aeglea Biotherapeutics, Inc.(AGLEUSD) | COM | 00773J103 | $19.1K | 2,700,000 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $18.8K | 5,558,425 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $18.4K | 1,431,059 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $14.4K | 1,000,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $11.2K | 1,648,485 | 0.0% |
| Arya Sciences Acquisition Corp III | COM CL A | G3166W106 | $10.8K | 1,000,000 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $7.9K | 3,871,164 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $5.2K | 500,000 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $5.0K | 500,000 | 0.0% |